Citation Impact
Citing Papers
Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study
2017 Standout
Breast cancer
2019 Standout
Gemcitabine, cisplatin and methylprednisolone (GEM-P) is an effective salvage regimen in patients with relapsed and refractory lymphoma
2005
Caring for frail older people in the last phase of life – the general practitioners’ view
2016
Guidelines for colorectal cancer: Effects on nutritional intervention
2007
Factors influencing death at home in terminally ill patients with cancer: systematic review
2006 Standout
Molecular mechanisms of resistance and toxicity associated with platinating agents
2006 Standout
Perioperative fasting in adults and children
2011
Heterogeneity and changes in preferences for dying at home: a systematic review
2013 Standout
Essential oils from aromatic herbs as antimicrobial agents
2011 Standout
Supportive Cryotherapy: A Review From Head to Toe
2013
2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours
2010 Standout
Rituximab, gemcitabine and oxaliplatin: an effective salvage regimen for patients with relapsed or refractory B-cell lymphoma not candidates for high-dose therapy
2007
Pseudomonas Skin Infection
2011
Frailty: implications for clinical practice and public health
2019 Standout
GEMOX‐R regimen is a highly effective salvage regimen in patients with refractory/relapsing diffuse large‐cell lymphoma: a phase II study
2007
Salvage Therapy for Relapsed/Refractory Diffuse Large B Cell Lymphoma
2008
Seborrheic Dermatitis
2009
Single-Agent Pixantrone as a Bridge to Autologous Stem Cell Transplantation in a Patient with Refractory Diffuse Large B-Cell Lymphoma
2017 Standout
Guidelines for enhanced recovery after lung surgery: recommendations of the Enhanced Recovery After Surgery (ERAS®) Society and the European Society of Thoracic Surgeons (ESTS)
2018 Standout
Cisplatin as an Anti-Tumor Drug: Cellular Mechanisms of Activity, Drug Resistance and Induced Side Effects
2011 Standout
The side effects of platinum-based chemotherapy drugs: a review for chemists
2018 Standout
Dissemination and publication of research findings: an updated review of related biases
2010 Standout
Printed educational materials: effects on professional practice and healthcare outcomes
2012 Standout
Cellular and molecular aspects of drugs of the future: oxaliplatin
2002
A terminal diagnosis: The carers’ perspective
2007
Comparative toxicities of 3 platinum‐containing chemotherapy regimens in relapsed/refractory lymphoma patients
2016
Guidelines for Perioperative Care in Elective Colonic Surgery: Enhanced Recovery After Surgery (ERAS®) Society Recommendations
2012 Standout
The International Workshop on Meibomian Gland Dysfunction: Report of the Definition and Classification Subcommittee
2011 Standout
Guidelines for Perioperative Care in Elective Rectal/Pelvic Surgery: Enhanced Recovery After Surgery (ERAS®) Society Recommendations
2012 Standout
Works of Anne Howard being referenced
Developing palliative care practice in the community
2002
An oxaliplatin‐based chemotherapy in patients with relapsed or refractory intermediate and high‐grade non‐Hodgkin's lymphoma
2001
Task Force Report:The legal implications of medical guidelines— a Task Force of the European Society of Cardiology
1999
Efficacy, cutaneous tolerance and cosmetic acceptability of desonide 0.05% lotion (Desowen®) versus vehicle in the short‐term treatment of facial atopic or seborrhoeic dermatitis
2002
Docetaxel‐induced nail dystrophy
2002
Place of death: Hobson’s Choice or patient choice?
2003
Pseudomonas chloronychia in a patient with nail psoriasis
2007